Post-operative radiation therapy has been used in selected patients wi
th colon cancer. In contrast with rectal cancer, the primary failure p
attern in colon cancer is abdominal. Local failure does occur, but is
less frequent and more difficult to detect. Retrospective data suggest
a benefit from local/regional radiation therapy on local control and
disease-free survival in subsets of patients compared to historical co
ntrols. An ongoing phase III intergroup trial (INT 0130) will determin
e if local/regional radiation therapy improves the results of chemothe
rapy in subsets of patients with high-risk colon cancer. In general, t
he results of whole abdominal radiation plus 5-fluorouracil (5-FU) hav
e been disappointing. However, the more recent data from the Southwest
Oncology Group pilot trial are encouraging. In contrast to rectal can
cer, where adjuvant chemotherapy plus radiation therapy is standard tr
eatment in high-risk patients, the use of radiation therapy (either lo
cal/regional or whole abdomen) in colon cancer remains investigational
.